Department Of Hematology and Oncology
Rajshekhar Chakraborty, MD
Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by fellowship in hematology/oncology at the Cleveland Clinic.

During fellowship, he conducted outcomes research with a focus on quality of life and treatment-related toxicities in plasma cell disorders. After fellowship, he started his job as Assistant Professor of Medicine at the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center.

Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom’s macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.

Clinical Studies Managed By This Investigator:
Condition Study Title
Multiple Myeloma Study of Daratumumab in Addition to Chemotherapy for Patients with Smoldering Multiple Myeloma (SMM)
Multiple Myeloma Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis
Multiple Myeloma [ CLOSED ] Study of STI-6129 in Patients with Relapse/Refractory Multiple Myeloma (RRMM)
Multiple Myeloma Study of REGN5458 in Patients with Multiple Myeloma
Amyloidosis Study of Birtamimab in Patients with Mayo Stage IV (AL) Amyloidosis
Multiple Myeloma Study of Linvoseltamab in Patients with Multiple Myeloma (NDMM)
Amyloidosis Study of ABBV-383 in Patients with Amyloidosis